Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CVR Medical Corp
V.CVM.H
Alternate Symbol(s):
CRRVF
Healthcare
Medical Devices
CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool...
, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CVM.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Jan 02, 2023 3:48pm
RE:RE:RE:RE:Restructuring news is up on website
I think the point is that they have been no more shares issued so there's not been any dilution but the shares that were held in Escrow have now been released to CVR global which means that when
...more
(4)
•••
wealth100
X
View Profile
View Bullboard History
Comment by
wealth100
on Jan 01, 2023 11:27am
RE:RE:RE:Restructuring news is up on website
oldtimer, how did you determine the 100M and 180M shares?
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(10)
•••
oldtimer42
X
View Profile
View Bullboard History
Comment by
oldtimer42
on Dec 28, 2022 11:36am
RE:RE:Restructuring news is up on website
The explosion of the number of outstanding shares from a bit over 100 million to about 180 million really dilutes things. They will all be worthless without serious financing to cover the debt and
...more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Dec 27, 2022 3:39pm
RE:Restructuring news is up on website
So the tsx has to approve this and is this going to a vote? Wonder how long till anything g happens
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Post by
Looneytunes
on Dec 27, 2022 10:16am
Restructuring news is up on website
https://cvrmed.com/cvr-medical-corp-announces-amended-restructuring-agreement-with-cvr-global-inc/
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Dec 22, 2022 6:48pm
RE:RE:RE:RE:Further dilution
Suspended on nex Sitting at pesos on otc
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Dec 22, 2022 5:09pm
RE:RE:RE:Further dilution
They are on the NEX and OTC, see tye link in my earlier post for the NEX listing details
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Dec 22, 2022 4:11pm
RE:RE:Further dilution
Are they gonna be trading again? Are they anywhere?
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Dec 21, 2022 5:19pm
RE:Further dilution
I don't think there is any further dilution yet as the shares had already been issued but just held in escrow but I'm pretty sure there will need to be further dilution to fund getting the
...more
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Comment by
Abovenbeyond
on Dec 20, 2022 6:43pm
RE:RE:Another kick at the can,
The fda Consultants shouldn't get anything. They advised the wrong number of clinical trials and wasted an attempt at approval. To me they didn't do their job so shouldn't be paid.
(10)
•••
Looneytunes
X
View Profile
View Bullboard History
Comment by
Looneytunes
on Dec 20, 2022 5:36pm
RE:Another kick at the can,
We'll need to hope the debt can be restructured so that full payment usnt beeded straight away otherwise we could see another 300 million shares in issue. This statement leaves as many
...more
(1)
•••
jarvis117
X
View Profile
View Bullboard History
Post by
jarvis117
on Dec 20, 2022 3:04pm
There's possible life here
Maybe all isn't lost for investors...
(5)
•••
Abovenbeyond
X
View Profile
View Bullboard History
Post by
Abovenbeyond
on Dec 20, 2022 2:49pm
Further dilution
But moving forward
(413)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Dec 20, 2022 2:20pm
Another kick at the can,
Keeping a close eye on this now that talks have settled a few housecleaning items. So, any guesses when trading resumes and can this company pay off its debts without insolvency? If so will the CSS
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >